Sponsor content
36 result(s) found, displaying 11 to 20
-
Australian public assessment report (AusPar)YORVIPATH (palopegteriparatide) is a parathyroid hormone analogue for the treatment of chronic hypoparathyroidism in adults.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for YORVIPATH palopegteriparatide 420 micrograms / 1.4 mL solution for injection in multidose pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for YORVIPATH palopegteriparatide 168 micrograms / 0.56 mL solution for injection in multidose pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for YORVIPATH palopegteriparatide 294 micrograms / 0.98 mL solution for injection in multidose pre-filled pen.
-
Jun-2025Prescription medicine evaluationActive ingredient: lurbinectedin.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Specialised Therapeutics Pharma Pty Ltd - Empty self-injector, electronic.
-
Prescription medicine registrationActive ingredients: lonapegsomatropin.
-
Prescription medicine registrationActive ingredients: palopegteriparatide.
-
Designation or determinationOrphan drug
-
Designation or determinationPriority review